Across TCGA pan-cancer cohorts, OR7E122P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of OR7E122P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where OR7E122P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7E122P is over-expressed in tumor, although a few such as LUSC and COAD show the opposite, repressed pattern.

BRCA, LUSC, and BLCA are the cancer types where OR7E122P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E122P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	+0.188	<.001	6	view →
LUSC	All	II,III,IV	−0.216	.004	3	view →
BLCA	Female	All	+0.057	.023	2	view →
CHOL	All	All	+0.063	.035	1	view →
COAD	Female	All	−0.013	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: OR7E122P RNA expression & survival · all OR7E122P data types